A Sensitive Docetaxel Assay in Plasma by Solid-Phase Extraction and High Performance Liquid Chromatography – UV Detection: Validation and Suitability in Phase I Clinical Trial Pharmacokinetics
- 1 November 1999
- journal article
- clinical trial
- Published by Springer Nature in Investigational New Drugs
- Vol. 17 (4) , 325-333
- https://doi.org/10.1023/a:1006327302041
Abstract
We have developed a specific and sensitive method aiming atdocetaxel (Taxotere®) determination in plasma of treatedpatients. This involved solid-phase extraction of 1 ml of plasmaonto carboxylic acid...Keywords
This publication has 22 references indexed in Scilit:
- Standards of laboratory practice: antiepileptic drug monitoring. National Academy of Clinical Biochemistry.1998
- Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer.Journal of Clinical Oncology, 1998
- Antitumor activity of docetaxel.1997
- Combination docetaxel/cyclophosphamide in patients with advanced solid tumors.1997
- Reflections on the development of resistance during therapy for advanced breast cancer. Implications of high levels of activity of docetaxel in anthracycline-resistant breast cancer patients.European Journal Of Cancer, 1997
- Sensitive determination of docetaxel in human plasma by liquid–liquid extraction and reversed-phase high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1997
- Weekly paclitaxel with and without concurrent radiation therapy: toxicity, pharmacokinetics, and response.1996
- Determination of paclitaxel in biological fluids by micellar electrokinetic chromatographyJournal of Chromatography A, 1996
- Determination of Taxotere in human plasma by a semi-automated high-performance liquid chromatographic methodJournal of Chromatography B: Biomedical Sciences and Applications, 1992
- Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue.1991